openPR Logo
Press release

Urinary Incontinence - Pipeline Review, H1 2017

10-02-2017 06:18 PM CET | Health & Medicine

Press release from: ReportsWeb

Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Pipeline Review, H1 2017, provides an overview of the Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline landscape.

Urinary incontinence is a loss of control of the bladder. In some cases, it may result in a total loss of the bladder’s contents or it may just cause minor leakage. Symptoms include stress incontinence, rashes and other skin disorders. Risk factors include age, gender, overweight, smoking and other kidney diseases. Treatment includes anticholinergics and topical estrogen.

Report Highlights

Publisher's Pharmaceutical and Healthcare latest pipeline guide Urinary Incontinence - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Urinary Incontinence (Genito Urinary System And Sex Hormones), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Get Sample Copy of Report@ http://www.reportsweb.com/inquiry&RW0001689419/sample

The Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Urinary Incontinence and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 4, 4, 1, 3 and 1 respectively. Similarly, the Universities portfolio in Phase II stages comprises 1 molecules, respectively.

Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Find More Information@ http://www.reportsweb.com/urinary-incontinence-pipeline-review-h1-2017

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

List of Tables

Number of Products under Development for Urinary Incontinence, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Products under Development by Companies, H1 2017
Products under Development by Universities/Institutes, H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Urinary Incontinence - Pipeline by Astellas Pharma Inc, H1 2017
Urinary Incontinence - Pipeline by Celogos SA, H1 2017
Urinary Incontinence - Pipeline by Cook MyoSite Inc, H1 2017
Urinary Incontinence - Pipeline by FemmePharma Global Healthcare Inc, H1 2017
Urinary Incontinence - Pipeline by GTx Inc, H1 2017
Urinary Incontinence - Pipeline by Innovacell Biotechnologie AG, H1 2017
Urinary Incontinence - Pipeline by Ipsen SA, H1 2017
Urinary Incontinence - Pipeline by Outpost Medicine Ltd, H1 2017
Urinary Incontinence - Pipeline by Pfizer Inc, H1 2017
Urinary Incontinence - Pipeline by Taiho Pharmaceutical Co Ltd, H1 2017
Urinary Incontinence - Pipeline by Takeda Pharmaceutical Company Ltd, H1 2017
Urinary Incontinence - Dormant Projects, H1 2017
Urinary Incontinence - Dormant Projects, H1 2017 (Contd..1), H1 2017
Urinary Incontinence - Discontinued Products, H1 2017

Buy This Report@ http://www.reportsweb.com/buy&RW0001689419/buy/2000

List of Figures

Number of Products under Development for Urinary Incontinence, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products by Targets, H1 2017
Number of Products by Stage and Targets, H1 2017
Number of Products by Mechanism of Actions, H1 2017
Number of Products by Stage and Mechanism of Actions, H1 2017
Number of Products by Routes of Administration, H1 2017
Number of Products by Stage and Top 10 Routes of Administration, H1 2017
Number of Products by Molecule Types, H1 2017
Number of Products by Stage and Molecule Types, H1 2017

About ReportsWeb:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

Contact Us:
Call: +1-646-491-9876
Email: sales@reportsweb.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Urinary Incontinence - Pipeline Review, H1 2017 here

News-ID: 750549 • Views:

More Releases from ReportsWeb

North America: Smart Airport Market Overall Study Report 2020-2026| Amadeus IT Group S.A., Cisco, Honeywell, IBM, QinetiQ Group Plc, Sabre Corporation, Siemens ,Rockwell Collins Inc, Thales Group and T Systems International GmbH
North America: Smart Airport Market Overall Study Report 2020-2026| Amadeus IT G …
The "Global North America Smart Airport Market: 2020" Industry Report is a professional and in-depth study on the current state of the North America Smart Airport Market by PMR. The North America Smart Airport market is supposed to demonstrate a considerable growth during the forecast period of 2020 - 2026. The company profiles of all the key players and brands that are dominating the market have been given in this
Marine Biotechnology Market Future Forecast 2018-2026 by Leading Companies such as BASF, Abbott Laboratories, Lonza Group, Nofima, Aker Biomarine, Cyanotech Corporation, New England Biolabs, GlycoMar, Pharmamara, Nutrex Hawaii Incorporated, Marinova, Fmc
Marine Biotechnology Market Future Forecast 2018-2026 by Leading Companies such …
ReportsWeb.com has announced the addition of the “Marine Biotechnology-Global Market Outlook 2017-2026” The report classifies the global Marine Biotechnology Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. According to Publisher, the Global Marine Biotechnology Market is accounted for $3.93 billion in 2017 and is expected to reach $8.74 billion by 2026 growing at a CAGR of 9.3% during
Anti-Counterfeiting Packaging Market Growth Opportunities and Emerging Trends by Analysis of Key Vendors like Alien Technology, 3M Company, Acg Pharmapack, Advanced Track & Trace, AlpVision S.A., Angstrom Technologies, Atlantic Zeiser, TruTag Technologies
Anti-Counterfeiting Packaging Market Growth Opportunities and Emerging Trends by …
ReportsWeb.com has announced the addition of the “Anti-Counterfeiting Packaging-Global Market Outlook 2017-2026” The report classifies the global Anti-Counterfeiting Packaging Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. According to Publisher, the Global Anti-Counterfeiting Packaging Market is accounted for $112.16 billion in 2017 and is expected to reach $427.96 billion by 2026 growing at a CAGR of 16.0% during
Solar Photovoltaic in Italy Market Outlook to 2030 | Company Profiles (Tozzi Holding, Silver Ridge Power, RTR Capital, Mitsubishi Corporation, Etrion Corporation)
Solar Photovoltaic in Italy Market Outlook to 2030 | Company Profiles (Tozzi Hol …
Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles Summary "Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles", is the latest report from Publisher, the industry analysis specialists that offer comprehensive information and understanding of the Solar Photovoltaic (PV) market in Italy. The report provides in depth analysis on global renewable power market and

All 4 Releases


More Releases for Urinary

Urinary Incontinence - Drug Pipeline Landscape, 2022
Urinary incontinence (UI) is the involuntary leakage of urine. UI happens when the muscles in the bladder that control the flow of urine contract or relax involuntarily, resulting in leaks or uncontrolled urination. The common causes of urinary incontinence include overactive bladder muscles, weakened pelvic floor muscles, nerve damage, interstitial cystitis (chronic bladder inflammation), obstruction, neurological disorders such as multiple sclerosis, stroke, or parkinson's disease. Urinary incontinence may also be caused
Urinary Incontinence Market Growing by Digital Therapeutic Device Improves Urina …
Demand Analysis of Urinary Incontinence Market Overview: The Urinary Incontinence Market is predicted to grow at a moderate CAGR of 8.42% during the forecast period covering 2020 to 2029. Urinary Incontinence Market share is estimated to reach a value of nearly US$ 6,718 million by 2029. The "Urinary Incontinence Market" think about 2022, the industry landscape is secured from driving factors to upstream markets and the by and large state of the
Urinary Incontinence Treatment Devices Market: High Prevalence of Urinary Incont …
The global urinary incontinence treatment devices market is driven by high prevalence and rapidly increasing incidence of urinary incontinence across the globe. The global market was valued at US$ 2.08 Bn in 2017 and is projected to expand at a CAGR of 7.4% from 2018 to 2026 to reach US$ 3.92 Bn by 2026. High growth of the market is attributed to increase in adoption, easy availability of electrical vaginal
Urinary Incontinence - Pipeline Review, H1 2018
"The Report Urinary Incontinence - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Urinary Incontinence Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Pipeline Review, H1 2018, provides an overview of the Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline landscape. Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1509366 Urinary incontinence
Increasing Number of Surgical Procedures and Urinary Incontinence is Likely to D …
Urinary catheter is flexible tube, generally made up of silicone, latex or polyurethane, inserted through the tube that carries urine to collect the urine in a drainage bag. Urinary catheters are inserted by doctors or nurses through small opening created to a lower abdomen. With increased stress at workplaces and busy lifestyles of the people worldwide, the number of health disorders such as bladder dysfunction, kidney failure, chronic diseases and
Urinary Catheters Industry Report 2017
Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Urinary Catheters for these regions, from 2012 to 2022 (forecast), covering • United States • China • Europe • Japan • Southeast Asia • India Global Urinary Catheters market competition by top manufacturers/players, with Urinary Catheters sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including, • TE Connectivity Corporation • C.R. Bard Inc. • B.Braun Melsungen AG • Coloplast • Cook Medical • Boston Scientific